Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeine for Antidepressant-induced Arousal Dysfunction
NCT05685407Phase 1Completed
- Sponsor
- University of Texas at Austin
- Start
- Jan 2023
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Sexual Arousal Disorder comparing Caffeine with Placebo (2 arms). Primary endpoint: Vaginal pulse amplitude via vaginal photoplethysmography. Started Jan 2023; status: completed.
02
Drugs
caffeine
03
Conditions
Sexual Arousal Disorder
Beyond the preview
Go deeper on NCT05685407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05685407.